Akero Therapeutics, Inc.
Akero Therapeutics, Inc. (AKRO) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 580 transactions totaling $327.1M, demonstrating a bearish sentiment with -$87.7M in net insider flow. The most recent transaction on Dec 9, 2025 involved a transaction of 152,616 shares valued at $0.
AKRO Insider Activity Summary
Who Is Buying AKRO Stock?
No significant insider buying has been recorded for AKRO in the recent period.
Who Is Selling AKRO Stock?
No significant insider selling has been recorded for AKRO in the recent period.
Is Akero Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AKRO is bearish with an Insider Alignment Score of 37/100 and a net flow of -$87.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
AKRO Frequently Asked Questions
Understanding AKRO Insider Activity
Insider trading at Akero Therapeutics, Inc. (AKRO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading AKRO stock, having executed 580 transactions in the past 90 days. The most active insider is Trust Skorpios (Executive), who has made 1 transactions totaling $71.2M.
Related Tools
Track Akero Therapeutics, Inc. Insider Activity
Get notified when executives and directors at AKRO file new Form 4 transactions